BDNF and Alzheimer disease: Research on BDNF as a potential peripheral biomarker of AD is supported by its ability to cross the blood–brain barrier [63,64] and by studies providing evidence of a correlation between the BDNF levels in the peripheral blood and the amount of BDNF in the CNS [65,66].